Abstract Dominant optic atrophy (DOA) is because of mutations in the mitochondrial protein OPA1. The disease principally affects retinal ganglion cells, whose axons degenerate leading to vision impairments, and sometimes other neuronal phenotypes. The exact mechanisms underlying DOA pathogenesis are not known. We previously demonstrated that the main role of OPA1, as a mitochondrial fusogenic and anti-apoptotic protein, are inhibited by interaction with the stress inducible pro-apoptotic BNIP3 protein. Because BNIP3 was recently reported to participate in autophagy and mitophagy, we tested the involvement of these processes in DOA pathogenesis. Using an in vitro neuronal model of DOA, we identified a BNIP3 down-regulation that reduced autophagy and mitophagy. Restoring BNIP3 had a biphasic effect, first rescuing autophagy and mitophagy levels but later leading to cell death. Similarly, in an in vivo mouse model of DOA, we showed that BNIP3 levels are decreased in young adult mice and increase to normal levels upon aging, paralleling disease progression. Altogether, our results indicate that the relationship between OPA1 and BNIP3 may have important bearings on DOA pathogenesis.
Dominant optic atrophy (DOA) primarily affects retinal ganglion cells (RGC), whose axons form the optic nerves, which degenerate in the condition (Lenaers et al. 2009 ). The main form of DOA is because of mutations in the OPA1 gene (Alexander et al. 2000; Delettre et al. 2000) . Up to 20% of DOA patients develop additional extra-ocular neurological complications (Yu- Wai-Man et al. 2010; Chao de la Barca et al. 2015) .
OPA1 is an inner mitochondrial membrane protein (Olichon et al. 2002) , which promotes the fusion of the organelle (Olichon et al. 2003) . The constant fusion and fission of mitochondria, i.e. mitochondrial dynamics, controls their shape, allows their adaptation to energetic needs, and participates in their quality control by restoring or removing damaged organelles or eventually precipitates apoptosis in cells . Mitochondrial dynamics are controlled by large GTPases, such as OPA1, which together with mitofusins 1 and 2, promote fusion, in contrast to the pro-fission protein DRP1. In addition, OPA1 has an independent anti-apoptotic activity (Olichon et al. 2003; Olichon et al. 2007; Cipolat et al. 2004 ) because of its tightening of cristae junctions, a process that sequesters cytochrome c (Frezza et al. 2006) . We previously showed that BNIP3, a pro-apoptotic member of the Bcl-2 family, whose expression is induced by stresses such as hypoxia (Guo et al. 2001) , directly interacts with OPA1 and inactivates both its fusogenic and its anti-apoptotic functions (Landes et al. 2010) . Recently, BNIP3 was reported to induce autophagy and to act as a mitochondrial receptor that tethers mitochondria to autophagosomes (Hanna et al. 2012) , prompting us to question its role in mitochondrial quality control in relation with OPA1.
How the inactivation of OPA1 function leads to optic nerve degeneration, and more generally to neurodegeneration, still has to be elucidated. We addressed this question with an in vitro model of OPA1 haploinsufficiency, the main condition for DOA, based on primary cortical neurons according to the fact that DOA attempts are not restricted to RGC but also affect other neuronal subtypes (Yu- Wai-Man et al. 2010; Chao de la Barca et al. 2015) . In this model, we previously reported that OPA1 down-regulation led to fragmented mitochondria with altered distribution and respiration (Bertholet et al. 2013; Millet et al. 2016) . This was associated with a reduction of synapse quantity and a dendropathy, both being observed in vivo in RGC on a DOA mouse model (Williams et al. 2010 (Williams et al. , 2012 , validating our in vitro neuronal model of DOA. Recent data have placed synaptic loss at the onset of the pathological mechanisms involved in neurodegenerative diseases leading to apoptosis. However, although spontaneous apoptosis was described in several cell lines upon OPA1 loss (Olichon et al. 2003; Lee et al. 2004) , we showed that OPA1 inactivation per se did not result in neuronal apoptosis (Bertholet et al. 2013; Millet et al. 2016) . Moreover, others observed that smaller mitochondria are easily engulfed in autophagosomes (Twig and Shirihai 2011) . In light of these findings, we hypothesized a link between neuronal resilience and the efficiency of autophagy and mitophagy in our DOA model. We thus analyzed whether OPA1 down-regulated neurons were protected from cell death by autophagy and mitophagy and whether BNIP3 was involved in these processes.
Materials and methods

Animals
All animal procedures were approved by the CNRS/F ed eration de Recherche de Biologie de Toulouse Animal Experimentation Ethics Committee (C2EA-01) under the protocol number 01024-01.7.
Pregnant Wistar rats (Janvier) were delivered % 48 h before killing and kept with food and water ad libitum. Embryos were removed at Day 17 (D17) from intra pentobarbital (Ceva Sant e Animale, Libourne, France) anesthetized females and cortices were dissected as described in Bertholet et al. 2013 cover-slip and grown in Neurobasal A-25 medium supplemented with B27, L-glutamine, penicillin/streptomycin, amphotericin, and lactic acid as described in Bertholet et al. 2013 . Eventually, neurons were treated after 9 days in culture with 1 mM deferoxamine (DFO, Sigma, St Louis, MO, USA) for 8 h or 24 h or with 4 mM 3-methyladenine (3 MA, Sigma) for 24 h. 
Immunoblotting
Proteins were extracted either from primary cultured cortical neurons or mice cortices as described in Millet et al. 2016 . Protein extracts (40-100 lg) were subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis and blotted onto nitrocellulose membranes, which were first treated with various primary antibodies: anti-OPA1 (1/300, serum from Eurogentec, Liege, Belgium), anti-BNIP3 (1/1000, ab109362; Abcam, Cambridge, UK), anti-HSP60 (1/1000, H3524; Sigma), and anti-actin (1/100 000, MAB1501; Merck Millipore, Darmstad, Germany) and then with horseradish peroxidase-conjugated secondary antibodies (1/5000, ab6789 and ab6721; Abcam) as described in Bertholet et al. 2013 . After enhanced chemiluminescent detection, scanned photographic films were analyzed using the ImageJ software (imageJ.nih.gov).
Immunocytochemistry
As described in Bertholet et al. 2013 , primary cortical neurons were fixed, permeabilized, blocked, and incubated with various primary antibodies : ATP synthase (1/500, A21351; ThermoFisher Scientific, Waltham, MA, USA), beta3 tubulin (1/2000, Sigma T2200), and GFP (1/500, AB16901; Merck Millipore), then Alexaconjugated secondary antibodies (1/1000, ab150080 ab150113 ab150116; Abcam and A-11039; ThermoFisher Scientific) and finally Hoechst stained. Analyses of mitochondrial network morphology and cell death were performed on 50 neurons per condition, under the 1009 objective of a wide-field microscope (Nikon Eclipse 80i; Chiyoda, Japan). Analysis of autophagy and mitophagy was done on a confocal microsocope under the 639 objective zoom 5 (Leica Biphoton SP5, Microsystems, Wetlar, Germany; TRIGenotoul platform). After deconvolution (Huygens â software, svi.nl/Huygens), pictures were analyzed using the Volocity 3D Image Analysis software (cellularimaging.perkinelmer.com). Somas (80-140 per condition) were reconstructed in 3D according to Nyquist criteria (11 z-stacks, 1.4 lm) to allow automatic quantification of the number of autophagosomes and intersections between autophagosomes and mitochondria (threshold of 100 shared voxels).
Statistical analysis
Data were statistically treated using Graph Pad Prism software (graphpad.com) with Mann-Whitney tests because of systematic comparisons between either siCtrl-and siOPA1-transfected cells or vehicle and DFO-or 3-methyladenine (3MA)-treated cells. *p < 0.05, **p < 0.01, ***p < 0.001.
Results
Autophagy and mitophagy events are reduced in OPA1-depleted neurons To investigate the impact of OPA1 inactivation on autophagy and mitophagy, primary cortical neurons were transfected with small interfering RNA (siRNA) targeting OPA1 (siOPA1) or control siRNA (siCtrl) before seeding. After 9 days in vitro (DIV9), Western blot analysis revealed an effective knockdown (% 70%) of OPA1 expression (Fig. 1a) . The effect of siOPA1 on mitochondrial morphology, analyzed by fluorescence microscopy, was a 13-fold increase in the number of neurons exhibiting fragmented ATP synthase-labeled mitochondria (Fig. 1b) . The spontaneous apoptotic death rate, estimated by counting nuclei with condensed and fragmented chromatin, was unchanged (Fig. 1c) . However, OPA1 downregulation was accompanied by a % 1.4-fold decrease in the numbers of both autophagosomes and mitochondria inside autophagosomes observed after co-transfection of a GFPtagged autophagosome marker, LC3 (Fig. 1d) .
To determine whether a greater decrease in autophagy/ mitophagy could induce apoptosis, we used 3MA, which by inhibiting type III phosphatidylinositol 3-kinases is a potent inhibitor of autophagosomes formation (Klionsky et al. 2012) . Addition of 3MA increased apoptotic death rate in both siCrtl-and siOPA1-treated neurons (Fig. 1e) . To note OPA1 down-regulated neurons were 1.6-fold more sensitive than control neurons.
BNIP3 controls autophagy and mitophagy levels in OPA1-depleted neurons Upon OPA1 down-regulation, we revealed a % 40% reduction of BNIP3 protein levels in OPA1-depleted DIV9 neurons (Fig. 1a) . We then asked whether increasing the level of BNIP3 could restore autophagy and mitophagy. Since BNP3 was shown to be induced by hypoxia in a HIF-1a dependent manner (Guo et al. 2001) , we used DFO a mimetic of hypoxia that stabilizes the transcription factor HIF-1a . DFO was added for either a short or long time, since contrarily to other pro-apoptotic members of the Bcl-2 family the induction of apoptosis by BNIP3 was shown to be a slow process (Burton and Gibson 2009) .
After 8 h, DFO treatment increased the levels of BNIP3 by a factor 2.2 and 1.9 in siCtrl-and siOPA1-transfected neurons, respectively ( Fig. 2a and Fig. S1a ), without modifying OPA1 levels ( Fig. 2b and Fig. S1a) . Similarly, in both conditions, BNIP3 up-regulation correlated with 1.4-to 1.8-fold increases in autophagy (Fig. 2c and Fig. S1b ) and mitophagy ( Fig. 2d and Fig. S1c) . Interestingly, upon DFO induction, BNIP3 and autophagy/mitophagy levels in siOPA1 neurons were close to basal control levels (Fig. 2a,  c and d) . The spontaneous apoptotic death rate was similar in all conditions (Fig. 2e) . DFO induced a marked mitochondrial fragmentation in control neurons and led to a higher level of fragmentation in siOPA1-treated neurons (Fig. 2f) .
After 24 h, DFO treatment increased BNIP3 levels in both siCtrl-and siOPA1-transfected neurons by a factor 2.4 and 3.7, respectively ( Fig. 3a and Fig. S1a ), without drastic modification of OPA1 levels ( Fig. 3b and Fig. S1a ). BNIP3 upregulation iscorrelated with similar marked increases inboththe number of neurons with apoptotic nuclei (Fig. 3c and Fig. S1d ) and mitochondrial fragmentation (Fig. 3d and Fig. S1d ).
Biphasic changes in BNIP3 levels in DOA mice upon aging To test whether a similar BNIP3 decrease occurred in vivo, we used a DOA mouse model, ENU-mutagenized mice (OPA1 enu/+ ) carrying a heterozygous splice site mutation (c.1065 + 5G?A) in the OPA1 gene, leading to an inframe deletion in the GTPase domain (Alavi et al. 2007 ). We observed a 60 to 70% decrease in OPA1 protein levels in the cortices of 4-, 10-, and 15-month-old OPA1 enu/+ mice when compared with wild-type OPA1 +/+ littermates at the same age ( Fig. 4a and d) . In 4-month-old OPA1 enu/+ mice, BNIP3 protein levels were decreased by a factor 1.7 when compared with wild-type littermates, but this difference no longer persisted in 10-and 15-month-old OPA1 enu/+ mice ( Fig. 4b and d) . The abundance of the mitochondrial protein HSP60 showed no significant difference in DOA and control mice in all conditions ( Fig. 4c  and d) . 
Discussion
In an in vitro neuronal model of DOA, we report that the down-regulation of OPA1 leads to a reduction in BNIP3 levels. Similarly, we show a lower BNIP3 level in vivo in a mouse model of OPA1 haploinsufficiency at 4 months of age. Because BNIP3 expression can be induced by various stressors such as hypoxia and reactive oxygen species (ROS) (Guo et al. 2001) , reciprocally the observed BNIP3 decrease because of OPA1 loss could reflect a reduction in total ROS levels, which indeed occurs in cortical neurons upon siOPA1-treatment as we previously showed in Bertholet et al. 2013 . Furthermore, we recently demonstrated in Millet et al. 2016 that such low ROS levels are the consequence of a rise in mitochondrial ROS-induced antioxidant defenses, activated to buffer ROS excess both in vitro and in vivo. However, upon aging, these antioxidant defenses were shown to be overwhelmed in OPA1 enu/+ mice, leading to oxidative stress ). This observation is in agreement with our current findings, of a transient in vivo BNIP3 decrease, returning to control levels in 10-and 15-month-old OPA1 enu/+ mice, suggesting an oxidative stress-dependent rise in BNIP3 expression. Down-regulation of OPA1 in primary cortical neurons induced mitochondrial fragmentation without significantly increasing spontaneous apoptotic cell death at DIV9, like at DIV6 as previously shown (Bertholet et al. 2013) . However, at DIV10, spontaneous cell death appeared increased (1.9 fold, p < 0.05) in siOPA1-treated neurons. This suggests that with time low levels of OPA1, like other additional exogenous stresses , impact neuronal survival. Accordingly, in the OPA1 enu/+ DOA mouse model, RGC loss increased upon aging (Alavi et al. 2007; Heiduschka et al. 2010; Nguyen et al. 2011; Gonzalez-Menendez et al. 2015) .
In terms of mitochondria quality control, our study demonstrates that OPA1 down-regulation led to decreases in the numbers of both autophagosomes and mitochondria in autophagosomes. Yet, because the reduction in OPA1 levels leads to mitochondrial fragmentation and a drop in mitochondrial membrane potential (Bertholet et al. 2013 ), these two conditions, known to induce mitophagy (Twig and Shirihai 2011) , should contrarily increase these phenomena. Moreover, over-expression of OPA1 inhibited mitophagy, as did inhibition of fission (Twig and Shirihai 2011) , and elongation of mitochondria through inhibition of DRP1 was shown to spare them from autophagic degradation during starvation (Gomes et al. 2011; Rambold et al. 2011) . We hypothesize that the observed decrease in neuronal autophagy/mitophagy upon OPA1 down-regulation could be the consequence of the reduction of BNIP3 levels because BNIP3 can induce autophagy and mitophagy (Hanna et al. 2012) . Our findings indeed validated this hypothesis because in OPA1-depleted neurons, increasing BNIP3 quantity to control levels restored both autophagy and mitophagy. Numerous data indicate that autophagy and mitophagy protect neurons from degeneration (Giordano et al. 2014) . In agreement, we report here that inhibition of autophagy through 3MA treatment affected the survival of both siCtrland siOPA1-treated neurons, showing that in both cases, spontaneous autophagy is a protective event. Notably, while reduction of autophagy/mitophagy by itself was not sufficient to induce spontaneous apoptotic cell death in siOPA1-treated neurons, inhibition of these processes by 3MA led to higher neuronal death than in control neurons. Thus, decreased autophagy/mitophagy probably contributes to the susceptibility of OPA1 down-regulated neurons to stresses.
Contrary to what we observed in vitro, an increased number of autophagosomes was observed in the optic nerves of another DOA mouse model (White et al. 2009 ). This observation occurred in very aged mice with highly damaged optic nerves and appeared as a sign of RGC degeneration rather than of protection. Accordingly, accumulation of autophagic structures was also described in a third DOA mouse model that presents a severe, multisystemic, polyneurodegenerative phenotype (Sarzi et al. 2012) . Increased autophagy in late stages is indeed a feature of number of neurologic diseases (Koch and Lingor 2016) .
While a short-term increase of BNIP3 levels in siOPA1-treated neurons had no effect on spontaneous apoptosis, long-term BNIP3 induction led to a marked cell death regardless of OPA1 levels. This result, which is in complete agreement with the fact that the induction of apoptotic cell death by BNIP3 is a slow process (Burton and Gibson 2009) , confirms the crucial position of BNIP3 at a cross-roads between cell survival and death.
Altogether, the present data and our recent results (Bertholet et al. 2013; Millet et al. 2016 ) suggest a sequence of events that could contribute to DOA pathogenesis. In the early stage, down-regulation of OPA1, through a redox imbalance that leads to reduction of ROS levels, is accompanied by a reduction of BNIP3 and, thus, of autophagy/ mitophagy levels, which contributes to sensitizing neurons to acute or chronic stresses. With time, the redox imbalance because of OPA1 down-regulation cannot be compensated for and leads to increased ROS levels, together with normal BNIP3 levels, whose long-term expression is deleterious for cell viability.
Since RGC are particularly exposed to light which generates oxidative species, the deregulation of BNIP3 expression could be particularly deleterious to this type of neurons contributing to their peculiar susceptibility, together with other parameters such as the huge energetic requirements to sustain high firing activity, the peculiar architecture with long axons experimenting orthogonal turn at the exit of the eyes, unequal distribution of axonal mitochondria which are enriched in prelaminar unmyelinated area and scare after the lamina in the myelinated part of the axons. If these characteristics are not all reproduced in our in vitro general model of DOA, it recapitulated neuronal impairments that were also evidenced in RGC of a DOA mouse model (Williams et al. 2010 (Williams et al. , 2012 Bertholet et al. 2013) , and points here for the first time the possible implication of alteration of autophagy/mitophagy in DOA pathogenesis.
Interestingly changes in OPA1 expression were evidenced in Alzheimer's disease (Wang et al. 2009 ), the protein was involved in the death of dopaminergic neurons in a model of Parkinson (Ramonet et al. 2013 ) and mutations of OPA1 lead to a Parkinsonian syndrome (Carelli et al. 2015) . Furthermore, BNIP3 was involved in neuronal death in various models of neurodegeneration, i.e. Alzheimer's (Zhang et al. 2007 ), Parkinson's (Zhang et al. 2010) , and Huntington's (Sassone et al. 2015) diseases. The dual function of BNIP3 as a death actor through its pro-apoptotic function and as a pro-survival actor through its proautophagic/mitophagic function, which is still controversial in neurons (Awan et al. 2014; Shi et al. 2014) , was clearly established in cardiomyocytes (Hamacher-Brady et al. 2006; Hu et al. 2014) . Interestingly, BNIP3 over-expression occurs upon myocardial infarct and cardiac failure (Regula et al. 2002; Graham et al. 2004 ) and low levels of OPA1 were detected in deficient hearts (Chen et al. 2009 ). Furthermore, OPA1 was recently shown to impact cardiac functions (Chen et al. 2012; Wai et al. 2015) . Altogether, these data underline the interest in studying the two partners and their impact on apoptosis and autophagy/mitophagy.
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